Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Interaction of a novel GDP exchange inhibitor with the Ras protein.
Ganguly AK, Wang YS, Pramanik BN, Doll RJ, Snow ME, Taveras AG, Remiszewski S, Cesarz D, del Rosario J, Vibulbhan B, Brown JE, Kirschmeier P, Huang EC, Heimark L, Tsarbopoulos A, Girijavallabhan VM, Aust RM, Brown EL, DeLisle DM, Fuhrman SA, Hendrickson TF, Kissinger CR, Love RA, Sisson WA, Webber SE, et al. Ganguly AK, et al. Among authors: cesarz d. Biochemistry. 1998 Nov 10;37(45):15631-7. doi: 10.1021/bi9805691. Biochemistry. 1998. PMID: 9843367
Ras oncoprotein inhibitors: the discovery of potent, ras nucleotide exchange inhibitors and the structural determination of a drug-protein complex.
Taveras AG, Remiszewski SW, Doll RJ, Cesarz D, Huang EC, Kirschmeier P, Pramanik BN, Snow ME, Wang YS, del Rosario JD, Vibulbhan B, Bauer BB, Brown JE, Carr D, Catino J, Evans CA, Girijavallabhan V, Heimark L, James L, Liberles S, Nash C, Perkins L, Senior MM, Tsarbopoulos A, Webber SE, et al. Taveras AG, et al. Among authors: cesarz d. Bioorg Med Chem. 1997 Jan;5(1):125-33. doi: 10.1016/s0968-0896(96)00202-7. Bioorg Med Chem. 1997. PMID: 9043664
Detection and structural characterization of ras oncoprotein-inhibitors complexes by electrospray mass spectrometry.
Ganguly AK, Pramanik BN, Huang EC, Liberles S, Heimark L, Liu YH, Tsarbopoulos A, Doll RJ, Taveras AG, Remiszewski S, Snow ME, Wang YS, Vibulbhan B, Cesarz D, Brown JE, del Rosario J, James L, Kirschmeier P, Girijavallabhan V. Ganguly AK, et al. Among authors: cesarz d. Bioorg Med Chem. 1997 May;5(5):817-20. doi: 10.1016/s0968-0896(97)00021-7. Bioorg Med Chem. 1997. PMID: 9208093
Tricyclic farnesyl protein transferase inhibitors: crystallographic and calorimetric studies of structure-activity relationships.
Strickland CL, Weber PC, Windsor WT, Wu Z, Le HV, Albanese MM, Alvarez CS, Cesarz D, del Rosario J, Deskus J, Mallams AK, Njoroge FG, Piwinski JJ, Remiszewski S, Rossman RR, Taveras AG, Vibulbhan B, Doll RJ, Girijavallabhan VM, Ganguly AK. Strickland CL, et al. Among authors: cesarz d. J Med Chem. 1999 Jun 17;42(12):2125-35. doi: 10.1021/jm990030g. J Med Chem. 1999. PMID: 10377218
N-hydroxy-3-phenyl-2-propenamides as novel inhibitors of human histone deacetylase with in vivo antitumor activity: discovery of (2E)-N-hydroxy-3-[4-[[(2-hydroxyethyl)[2-(1H-indol-3-yl)ethyl]amino]methyl]phenyl]-2-propenamide (NVP-LAQ824).
Remiszewski SW, Sambucetti LC, Bair KW, Bontempo J, Cesarz D, Chandramouli N, Chen R, Cheung M, Cornell-Kennon S, Dean K, Diamantidis G, France D, Green MA, Howell KL, Kashi R, Kwon P, Lassota P, Martin MS, Mou Y, Perez LB, Sharma S, Smith T, Sorensen E, Taplin F, Trogani N, Versace R, Walker H, Weltchek-Engler S, Wood A, Wu A, Atadja P. Remiszewski SW, et al. Among authors: cesarz d. J Med Chem. 2003 Oct 9;46(21):4609-24. doi: 10.1021/jm030235w. J Med Chem. 2003. PMID: 14521422
Synthesis and antitumor activity of ester-modified analogues of bengamide B.
Kinder FR Jr, Versace RW, Bair KW, Bontempo JM, Cesarz D, Chen S, Crews P, Czuchta AM, Jagoe CT, Mou Y, Nemzek R, Phillips PE, Tran LD, Wang RM, Weltchek S, Zabludoff S. Kinder FR Jr, et al. Among authors: cesarz d. J Med Chem. 2001 Oct 25;44(22):3692-9. doi: 10.1021/jm010188c. J Med Chem. 2001. PMID: 11606134
Retraction Note: The potential preventive role of a dietary supplement containing hydroxytyrosol in COVID-19: a multi-center study.
Dhuli K, Micheletti C, Medori MC, Madeo G, Bonetti G, Donato K, Gaffuri F, Tartaglia GM, Michelini S, Fiorentino A, Cesarz D, Connelly ST, Capodicasa N, Bertelli M. Dhuli K, et al. Among authors: cesarz d. Eur Rev Med Pharmacol Sci. 2024 Apr;28(8):3288. doi: 10.26355/eurrev_202404_36067. Eur Rev Med Pharmacol Sci. 2024. PMID: 38708488 Free article.
The potential preventive role of a dietary supplement containing hydroxytyrosol in COVID-19: a multi-center study.
Dhuli K, Micheletti C, Medori MC, Madeo G, Bonetti G, Donato K, Gaffuri F, Tartaglia GM, Michelini S, Fiorentino A, Cesarz D, Connelly ST, Capodicasa N, Bertelli M. Dhuli K, et al. Among authors: cesarz d. Eur Rev Med Pharmacol Sci. 2023 Dec;27(6 Suppl):33-38. doi: 10.26355/eurrev_202312_34687. Eur Rev Med Pharmacol Sci. 2023. Retraction in: Eur Rev Med Pharmacol Sci. 2024 Apr;28(8):3288. doi: 10.26355/eurrev_202404_36067 PMID: 38112946 Free article. Retracted. Clinical Trial.